2022
DOI: 10.1021/acs.oprd.2c00257
|View full text |Cite
|
Sign up to set email alerts
|

Regulatory Highlights

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 8 publications
0
1
0
Order By: Relevance
“…The emergence of nitrosamine impurities in Sartan and other marketed drugs has triggered a global effort to perform risk assessments for their potential presence during the manufacturing processes of drug substances in accordance with the current regulatory requests. …”
Section: A Condition Focused Prediction For Nitrosaminesmentioning
confidence: 99%
“…The emergence of nitrosamine impurities in Sartan and other marketed drugs has triggered a global effort to perform risk assessments for their potential presence during the manufacturing processes of drug substances in accordance with the current regulatory requests. …”
Section: A Condition Focused Prediction For Nitrosaminesmentioning
confidence: 99%